Curelo, a diagnostics platform started in 2022 by Dr. Arpit Jayswal, has reported a successful financing round, collecting $100,000 in funding from IIMA's CIIE.CO. The platform specialises in enabling patients to easily schedule at-home blood sample collections and quickly receive their blood tests from a lab of their choosing. Curelo provides sample collection within 60 minutes after booking and guarantees delivery to the chosen lab thanks to a team of phlebotomists. Based on test availability, cost, and response time, patients can also find labs on the site.

In its first 10 months of operation, Curelo has forged alliances with more than 1,350 labs, handled more than 125,000 orders, and now sustains a monthly run rate of INR 55 lakhs with a 30% growth rate month over month. In the near future, Curelo plans to diversify into the radiology and blood bank aggregator industries.

In order to show his enthusiasm, Mr. Vipul Patel, Partner - Seed Investments at CIIE.CO, said that Mr. Arpit had "deep insights into the customer pain points" due to his experience managing a network of multi-specialty hospitals and diagnostic labs. We are thrilled to work with the Curelo team and are looking forward to assisting them as they expand their enterprise.

We are honoured to have CIIE.CO support Curelo, said Dr. Arpit Jayswal, the company's founder and CEO. Their faith in us demonstrates the tremendous potential of both the diagnostic aggregator market and our technology. By year's end, we hope to provide over 1,000 home samples every day by scaling nationally, improving the user experience, and standardising sample collecting. We are excited to have the great sector knowledge and network of CIIE.CO accompany us on this journey.